Hartline Investment Corp Illumina, Inc. Transaction History

Hartline Investment Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$209.2 - $335.53 $1.01 Million - $1.61 Million	-4,807 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$288.29 - $335.49 $16,144 - $18,787	-56 Reduced 1.15%	4,807 $1.6 Million
Q3 2019 Nov 13, 2019	BUY	$266.84 - $378.23 $56,036 - $79,428	210 Added 4.51%	4,863 $1.48 Million
Q2 2019 Aug 08, 2019	BUY	$300.59 - $368.15 $93,182 - $114,126	310 Added 7.14%	4,653 $1.71 Million
Q1 2019 May 10, 2019	BUY	$272.57 - $321.18 $282,927 - $333,384	1,038 Added 31.41%	4,343 $1.35 Million
Q4 2018 Feb 13, 2019	SELL	$272.46 - $366.54 $1.74 Million - $2.34 Million	-6,371 Reduced 65.84%	3,305 $991,000
Q3 2018 Nov 09, 2018	BUY	$279.04 - $367.06 $2.7 Million - $3.55 Million	9,676 New	9,676 $3.55 Million

908

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Hartline Investment Corp with notifications on news.